Mingji Jin
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 37
- Nanoparticle-Based Drug Delivery 35
-
- Advanced Drug Delivery Systems 4
- Co-authors
- Zhonggao GaoLiqing ChenWei HuangLin KangQiming WangTony HunterYongsung KimXinde Zheng
- Journals
- International Journal of Nanomedicine (10 papers)Pharmaceutics (7 papers)Acta Pharmaceutica Sinica B (6 papers)Journal of Controlled Release (5 papers)Journal of Nanobiotechnology (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Mingji Jin
103 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 778
- Pharmaceutical Science 267
- Molecular Biology 1.5k
- Pharmacology 187
- Developmental Neuroscience 77
Countries citing papers authored by Mingji Jin
This map shows the geographic impact of Mingji Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingji Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingji Jin more than expected).
Fields of papers citing papers by Mingji Jin
This network shows the impact of papers produced by Mingji Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingji Jin. The network helps show where Mingji Jin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingji Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 18 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 67 | |
| 12 | 2023 | 56 | |
| 13 | 2022 | 21 | |
| 14 | 2021 | 10 | |
| 15 | 2021 | 49 | |
| 16 | 2016 | 37 | |
| 17 | 2015 | 13 | |
| 18 | 2015 | 2 | |
| 19 | 2009 | 88 | |
| 20 | 2006 | 20 |
About Mingji Jin
Mingji Jin is a scholar working on Biomaterials, Pharmaceutical Science, Oncology, Molecular Biology and Transplantation, having authored 106 papers that have together received 3.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (35 papers), RNA Interference and Gene Delivery (33 papers), Nanoplatforms for cancer theranostics (26 papers), Advanced biosensing and bioanalysis techniques (15 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (5 papers), Advanced Drug Delivery Systems (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Biomaterials (778 citations), Pharmaceutical Science (267 citations), Molecular Biology (1.5k citations), Pharmacology (187 citations) and Developmental Neuroscience (77 citations). Mingji Jin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhonggao Gao, Liqing Chen, Wei Huang, Wei Huang, Lin Kang, Qiming Wang, Tony Hunter, Yongsung Kim, Xinde Zheng and Leah Boyer. Their work appears in journals such as International Journal of Nanomedicine, Pharmaceutics, Acta Pharmaceutica Sinica B, Journal of Controlled Release and Journal of Nanobiotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.